ENDRA Life Sciences Shareholders Shape Future at Annual Meeting
Company Announcements

ENDRA Life Sciences Shareholders Shape Future at Annual Meeting

ENDRA Life Sciences (NDRA) just unveiled an update.

At the Annual Meeting, shareholders of the company made several key decisions that will shape its future. They elected five directors to the board, showing strong support with millions of votes in favor. Additionally, they gave the green light to executive compensation, the issuance of common stock upon warrant exercises, and ratified the appointment of RBSM LLP as the independent auditor for the upcoming fiscal year. Significantly, shareholders approved a charter amendment to expand the authorized share count and voted in favor of a reverse stock split, with the board later setting the ratio at 1-for-50. These moves demonstrate shareholder confidence in the company’s strategic direction and governance.

For a thorough assessment of NDRA stock, go to TipRanks’ Stock Analysis page.

Related Articles
Christine BrownIs NDRA a Buy, Before Earnings?
TheFlyENDRA Life Sciences Inc trading resumes
TheFlyENDRA Life Sciences Inc trading halted, volatility trading pause
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App